BCBS Louisiana Medical Policy Updates – May 2021

Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »

May 2021 BCBS Louisiana Medical Policy Updates:

• Circulating Tumor DNA Management of Non Small Cell Lung
• Exon Skipping Therapies for Duchenne Muscular Dystrophy
• Molecular Markers In Fine Needle Aspirates of the Thyroid
• Molecular Markers In Fine Needle Aspirates of the Thyroid
• Ablation of Peripheral Nerves to Treat Pain
• Adalimumab Humira
• Amniotic Membrane and Amniotic Fluid
• Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
• Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions
• Buprenorphine sublingual
• Chimeric Antigen Receptor T Cell therapy Cart
• Circulating Tumor DNA and Circulating Tumor Cells for Cancer
• Closure Devices for Patent foramen Ovale and Atrial Septal Defects
• Comprehensive Genomic Profiling for Selecting Targeted Cancer therapies
• Cryotherapy for the Treatment of Chronic Rhinitis
• Denosumab Xgeva
• Drug Eluting Sinus Stents and Implants for Postoperative
• Electrical Nerve Stimulation Devices
• Endovascular Stent Grafts for Disorders of the Thoracic Aorta
• Esketamine Spravato
• Fetal Surgery for Prenatally Diagnosed Malformations
• Gene Expression Profiling for Uveal Melanoma
• Genetic Testing for Alpha 1 Antitrypsin Deficiency
• Genetic Testing for Hereditary Pancreatic Cancer
• Genetic Testing for CHARGE Syndrome
• Genetic Testing for the Diagnosis of Inherited Peripheral Neuropathies
• Helidac Bismuth Subsalicylate Metronidazole Tetracycline
• Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
• Hematopoietic Stem Cell Transplantation for Primary Amyloidosis or Waldenstroms Macroglobulinemia
• Hematopoietic Stem Cell Transplantation in the Treatment of Germ Cell Tumors
• Hip Resurfacing
• Hydrogel Spacer Use During Radiotherapy for Prostate Cancer
• Hyperbaric Oxygen Pressurization HBO
• Immune Globulin therapy
• Inhaled Antibiotics for Cystic Fibrosistobramycin Tobi Tobi Podhaler Bethkis Cayston
• Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
• Intravitreal Corticosteroid Implants
• Inveltys Loteprednol Ophthalmic Suspension
• Islet Transplantation
• Lumasiran Oxlumo
• Magnetic Resonance Guided Focused Ultrasound
• Manipulation under Anesthesia
• Microprocessor Controlled Prostheses for the Lower Limb
• Microwave Tumor Ablation
• Naltrexone Implants Pellets
• Nasal Swell Body Ablation Reduction In the Treatment of Nasal Obstruction
• Non Steroidal Anti Inflammatory Drugs NSAIDs
• Noninvasive Prenatal Screening for Fetal Aneuploidies and Microdeletions, and Twin Zygosity Using Cell-Free Fetal DNA
• Novel Treatments for Sickle Cell Disease Adakveo Oxbryta
• Novel Treatments for Sickle Cell Disease Adakveo Oxbryta
• Osilodrostat Isturisa
• Overactive Bladder Medications Branded
• pasireotide Injection (Signifor®, Signifor LAR®)
• Percutaneous Electrical Stimulation PENS and Percutaneous Neuromodulation Therapy (PNT)
• Radioembolization for Primary and Metastatic Tumors of the Liver
• Radiofrequency Ablation of Primary or Metastatic Liver Tumors
• Radiofrequency Ablation of the Renal Sympathetic Nerves as a Treatment for Resistant Hypertension
• Radioimmunoscintigraphy Imaging (Monoclonal Antibody Imaging) With Indium-111 Capromab Pendetide for Prostate Cancer
• Rayaldeecalcifediol
• Rituximab Rituxan
• Ryclora Dexchlorpheniramine Oral Solution
• Selumetinib Koselugo
• Selumetinib Koselugo
• Selumetinib Koselugo
• thermography Archived Policy
• Topical Actinic Keratosis Products
• Topical Acne Products
• Topical Corticosteroids
• Treatment of IGF1 Deficiency
• Treatmentof Tinnitus
• Vacuum Assisted Closure of Chronic Wounds Negative Pressure Wound therapy
• Vagus Nerve Stimulation
• Vestibular Function Testing
• Whole Gland Cryoablation of Prostate Cancer
• Xyosted Testosterone Enanthate Auto Injection
• Zerviate Cetirizine Ophthalmic Solution

Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.